Clinicopathological study of neuro-glial damage biomarkers in central nervous system diseases
Not Applicable
- Conditions
- Multiple Sclerosis and allied disorders
- Registration Number
- JPRN-UMIN000006221
- Lead Sponsor
- Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who will not agree to the study design.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will bring us the promising tool in making dianogosis or therapeutic strategy in demyelinating diseases including multiple sclerosis and neuromyelitis optica
- Secondary Outcome Measures
Name Time Method